Progress and Challenges of Anti-VEGF Agents and Their Sustained-Release Strategies for Retinal Angiogenesis

Currently, the treatment for ocular neovascular diseases, including diabetic macular edema (DME) and age-related macular degeneration (AMD), mainly involves repeated intravitreal injection of anti-vascular endothelial growth factor (VEGF) drugs. Although it can preserve vision, repeated injections a...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Manhong, Fan, Ruiyan, Fan, Xiaoe, Shao, Yan, Li, Xiaorong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512290/
https://www.ncbi.nlm.nih.gov/pubmed/36172053
http://dx.doi.org/10.2147/DDDT.S383101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512290/
https://www.ncbi.nlm.nih.gov/pubmed/36172053
http://dx.doi.org/10.2147/DDDT.S383101

Ejemplares similares